KineMed, Inc. Demonstrates Uniquely Effective Biomarker Probes For CNS Drug Development at the 2011 World Pharmaceutical Congress

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Inc. (www.kinemed.com) announced today that Dr Mahalakshmi Shankaran, Ph.D., Director of Neurobiology, will present at the 2011 World Pharmaceutical Congress on Tuesday June 7th at 3:05 p.m. at the Sheraton Philadelphia City Center Hotel, Philadelphia, PA. Dr. Shankaran’s presentation, entitled “Novel Tissue and CSF Biomarkers Targeting Causal Pathways and Network Dynamics in Neurodegenerative Disease” will highlight KineMed’s unique ability to track the kinetics of neuronal transport and neurogenesis, using its proprietary high-throughput mass spectrometry platform to probe changes in the state of the living proteome.

MORE ON THIS TOPIC